These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Exceptions or alternatives to labeling requirements for products held by the Strategic National Stockpile. Final rule.
    Author: Food and Drug Administration, HHS.
    Journal: Fed Regist; 2012 Feb 06; 77(24):5696-9. PubMed ID: 22359804.
    Abstract:
    The Food and Drug Administration (FDA) is adopting as a final rule, without change, the interim final rule that issued regulations permitting FDA Center Directors to grant exceptions or alternatives to certain regulatory labeling requirements applicable to human drugs, biological products, or medical devices that are or will be included in the Strategic National Stockpile (SNS). FDA is taking this action to complete the rulemaking initiated with the interim final rule.
    [Abstract] [Full Text] [Related] [New Search]